Novartis' Bet Pays Off as Advanced Accelerator Applications Wins FDA Nod for Lutathera Post author:Sam Post published:January 25, 2018 Post category:BioPharma The drug is the first available FDA-approved Peptide Receptor Radionuclide Therapy. Source: BioSpace You Might Also Like It's Official: New FDA Head Confirmed May 9, 2017 One-Year Old Dracen Pharma Raises $40.5M, Hunts for Office and Lab Space With Plans to Hire January 29, 2018 HEALTHSOUTH Reports Strong Revenue And Earnings Growth For Fourth Quarter 2016 And Reiterates Full-Year 2017 Guidance February 21, 2017
One-Year Old Dracen Pharma Raises $40.5M, Hunts for Office and Lab Space With Plans to Hire January 29, 2018
HEALTHSOUTH Reports Strong Revenue And Earnings Growth For Fourth Quarter 2016 And Reiterates Full-Year 2017 Guidance February 21, 2017
